Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Vivus
Company Monitoring Page for Vivus
latest headlines for company on cafepharma
Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Wed, 03/31/10 - 09:51 pm
Tags:
Orexigen
,
FDA
,
obesity
,
Contrave
,
Vivus
,
Arena Pharmaceuticals
,
Qnexa
Vivus ends development agreement with FemPharm
Yahoo/AP
Wed, 03/31/10 - 09:36 am
Tags:
Vivus
,
FemPharm
,
testosterone
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
Tags:
FDA
,
obesity
,
Vivus
,
Orexigen
,
Arena Pharmaceuticals
,
Qnexa
,
Amylin
Bulls Anticipating a Vivus Upside
Seeking Alpha
Sat, 03/27/10 - 11:15 am
Tags:
Vivus
,
obesity
,
Qnexa
FDA panel to review Vivus drug in July
Fierce Biotech
Fri, 03/26/10 - 09:09 am
Tags:
Vivus
,
FDA
,
obesity
,
Qnexa
What to Expect for Biotech Stocks
Minyanville
Fri, 03/19/10 - 09:03 am
Tags:
biotech
,
Cell Therapeutics
,
Somaxon
,
Dendreon
,
Allos
,
GenVec
,
Arena Pharmaceuticals
,
Vivus
3 Ways to Play the Obesity Drugs
TheStreet.com
Tue, 03/16/10 - 10:05 am
Tags:
obesity
,
Arena Pharmaceuticals
,
Vivus
,
Orexigen
,
Contrave
,
Qnexa
,
lorcaserin
Vivus Q4 loss nearly doubles to $13.2M
Bizjournals.com
Mon, 03/8/10 - 07:17 pm
Tags:
earnings
,
Vivus
FDA accepts Vivus application for obesity drug
Marketwatch
Mon, 03/1/10 - 09:57 am
Tags:
FDA
,
Vivus
,
obesity
,
Qnexa
Biotech Stock Mailbag: NexMed
TheStreet.com
Fri, 02/12/10 - 08:19 am
Tags:
NexMed
,
Sequenom
,
Vivus
,
Keryx
,
Targacept
,
Immunogen
,
Cell Therapeutics
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 10:58 am
Tags:
FDA
,
Cadence Pharmaceuticals
,
Acorda Therapeutics
,
Auxilium
,
Gilead Sciences
,
Shire
,
Amylin
,
Cell Therapeutics
,
Dendreon
,
InterMune
,
Amgen
,
Human Genome
,
NicOx
,
Vivus
,
Arena Pharmaceuticals
,
Orexigen
Five Drugs To Watch (Assuming FDA Approval)
Pharmalot
Mon, 02/1/10 - 10:07 am
Tags:
FDA
,
Dendreon
,
Provenge
,
Victoza
,
Novo Nordisk
,
Qnexa
,
Vivus
,
Prolia
,
Amgen
,
Bayer
,
JNJ
,
Xarelto
Investors betting heavily on Vivus obesity drug
Marketwatch
Thu, 01/21/10 - 07:49 am
Tags:
Vivus
,
obesity
,
Qnexa
Vivus reports positive data on ED drug candidate
Yahoo/AP
Mon, 01/11/10 - 11:27 am
Tags:
Vivus
,
erectile dysfunction
,
Avanafil
Drug stocks rise; MAP and Vivus gain on drug updates
Marketwatch
Mon, 01/11/10 - 11:11 am
Tags:
Vivus
,
drug stocks
,
MAP Pharmaceuticals
Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:14 am
Tags:
Arena Pharmaceuticals
,
Vivus
,
Orexigen
,
Novo Nordisk
,
Amylin
,
Eli Lilly
,
Biogen Idec
,
Acorda Therapeutics
,
Dendreon
,
MannKind
Vivus says mid-stage study shows its obesity drug candidate Qnexa reduced sleep apnea symptoms
Yahoo/AP
Thu, 01/7/10 - 11:10 am
Tags:
Vivus
,
Qnexa
,
sleep apnea
2010 FDA Decisions to Watch
Motley Fool
Sun, 01/3/10 - 11:39 am
Tags:
FDA
,
Pfizer
,
Nektar
,
MannKind
,
Afresa
,
Eli Lilly
,
Amylin
,
Dendreon
,
Vivus
,
Alkermes
,
Arena Pharmaceuticals
,
Orexigen
Vivus files application with FDA for obesity drug
Marketwatch
Tue, 12/29/09 - 09:14 am
Tags:
FDA
,
Vivus
,
obesity
,
Qnexa
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:54 am
Tags:
FDA
,
Dendreon
,
Arena Pharmaceuticals
,
Chelsea Therapeutics
,
Cephalon
,
Biodel
,
Auxilium
,
Novartis
,
Novo Nordisk
,
Shire
,
Vivus
,
MannKind
,
Acorda Therapeutics
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.